{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:30Z","timestamp":1707525090518},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,19]]},"DOI":"10.7759\/cureus.40641","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T16:54:11Z","timestamp":1687193651000},"source":"Crossref","is-referenced-by-count":0,"title":["Guillain-Barr\u00e9 Syndrome Presenting as Painful Weakness and Edema of the Legs: A Case Report"],"prefix":"10.7759","author":[{"given":"Amteshwar","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evani","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venus","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitasha","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Khaliq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011595","article-title":"Pain during the acute phase of Guillain-Barr\u00e9 syndrome","volume":"97","author":"Yao S","year":"2018","unstructured":"Yao S, Chen H, Zhang Q, et al.. Pain during the acute phase of Guillain-Barr\u00e9 syndrome. Medicine (Baltimore). 2018, 97:e11595. 10.1097\/MD.0000000000011595","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027351","article-title":"Efficacy of therapies in the treatment of Guillain-Barre syndrome: a network meta-analysis","volume":"100","author":"Lin J","year":"2021","unstructured":"Lin J, Gao Q, Xiao K, Tian D, Hu W, Han Z. Efficacy of therapies in the treatment of Guillain-Barre syndrome: a network meta-analysis. Medicine (Baltimore). 2021, 100:e27351. 10.1097\/MD.0000000000027351","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard SE","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FA, et al.. Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019, 15:671-83. 10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21246","article-title":"Post-COVID-19 Guillain-Barr\u00e9 syndrome: a case report with literature review","volume":"14","author":"Kaeley N","year":"2022","unstructured":"Kaeley N, Kabi A, Pillai A, Shankar T, Ameena M S S. Post-COVID-19 Guillain-Barr\u00e9 syndrome: a case report with literature review. Cureus. 2022, 14:e21246. 10.7759\/cureus.21246","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila N","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021, 397:1214-28. 10.1016\/S0140-6736(21)00517-1","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano G","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, et al.. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med. 2020, 382:2574-6. 10.1056\/NEJMc2009191","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.83087","article-title":"Treatment guidelines for Guillain-Barr\u00e9 syndrome","volume":"14","author":"Meena AK","year":"2011","unstructured":"Meena AK, Khadilkar SV, Murthy JM. Treatment guidelines for Guillain-Barr\u00e9 syndrome. Ann Indian Acad Neurol. 2011, 14:S73-81. 10.4103\/0972-2327.83087","journal-title":"Ann Indian Acad Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie MM","year":"2013","unstructured":"Dimachkie MM, Barohn RJ. Guillain-Barr\u00e9 syndrome and variants. Neurol Clin. 2013, 31:491-510. 10.1016\/j.ncl.2013.01.005","journal-title":"Neurol Clin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2016.1193006","article-title":"Guillain-Barr\u00e9 syndrome: causes, immunopathogenic mechanisms and treatment","volume":"12","author":"Jasti AK","year":"2016","unstructured":"Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. Guillain-Barr\u00e9 syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol. 2016, 12:1175-89. 10.1080\/1744666X.2016.1193006","journal-title":"Expert Rev Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.525699","article-title":"Case report: early-onset Guillain-Barre syndrome mimicking stroke","volume":"12","author":"Sun J","year":"2021","unstructured":"Sun J, Gao Y, Chi L, Cao Q, Ning Z, Nan G. Case report: early-onset Guillain-Barre syndrome mimicking stroke. Front Neurol. 2021, 12:525699. 10.3389\/fneur.2021.525699","journal-title":"Front Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.608130","article-title":"Intensive care and treatment of severe Guillain-Barr\u00e9 syndrome","volume":"12","author":"Shang P","year":"2021","unstructured":"Shang P, Feng J, Wu W, Zhang HL. Intensive care and treatment of severe Guillain-Barr\u00e9 syndrome. Front Pharmacol. 2021, 12:608130. 10.3389\/fphar.2021.608130","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.2706","article-title":"Forging ahead","volume":"12","author":"Anklesaria Z","year":"2017","unstructured":"Anklesaria Z, Hunt D, Shah M, Sharpe B, Monash B. Forging ahead. J Hosp Med. 2017, 12:188-92. 10.12788\/jhm.2706","journal-title":"J Hosp Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial","volume":"17","author":"Misawa S","year":"2018","unstructured":"Misawa S, Kuwabara S, Sato Y, et al.. Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol. 2018, 17:519-29. 10.1016\/S1474-4422(18)30114-5","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.678136","article-title":"Case report: Guillain-Barr\u00e9 syndrome associated with COVID-19","volume":"12","author":"Khedr EM","year":"2021","unstructured":"Khedr EM, Shoyb A, Mohamed KO, Karim AA, Saber M. Case report: Guillain-Barr\u00e9 syndrome associated with COVID-19. Front Neurol. 2021, 12:678136. 10.3389\/fneur.2021.678136","journal-title":"Front Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"Pain in Guillain-Barre syndrome: a long-term follow-up study","volume":"75","author":"Ruts L","year":"2010","unstructured":"Ruts L, Drenthen J, Jongen JL, Hop WC, Visser GH, Jacobs BC, van Doorn PA. Pain in Guillain-Barre syndrome: a long-term follow-up study. Neurology. 2010, 75:1439-47. 10.1212\/WNL.0b013e3181f88345","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2014.04.009","article-title":"Pain management in Guillain-Barre syndrome: a systematic review","volume":"30","author":"Pe\u00f1a L","year":"2015","unstructured":"Pe\u00f1a L, Moreno CB, Gutierrez-Alvarez AM. Pain management in Guillain-Barre syndrome: a systematic review. Neurologia. 2015, 30:433-8. 10.1016\/j.nrl.2014.04.009","journal-title":"Neurologia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009950.pub3","article-title":"Pharmacological treatment for pain in Guillain-Barr\u00e9 syndrome","volume":"2015","author":"Liu J","year":"2015","unstructured":"Liu J, Wang LN, McNicol ED. Pharmacological treatment for pain in Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2015, 2015:CD009950. 10.1002\/14651858.CD009950.pub3","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/162022-guillain-barr-syndrome-presenting-as-painful-weakness-and-edema-of-the-legs-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:09Z","timestamp":1707509109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/162022-guillain-barr-syndrome-presenting-as-painful-weakness-and-edema-of-the-legs-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.40641","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,19]]}}}